Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database

Ivan Foeldvari, Alan Tyndall, Francesco Zulian, Ulf Müller-Ladner, L. Czirják, Chris Denton, Ottilia Kowal-Bielecka, Dominique Farge Bancel, Marco Matucci-Cerinic

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective. The aim of the present study was to explore the long-term outcome and clinical characteristics of adult patients with juvenile onset in the EULAR Scleroderma Trials and Research (EUSTAR) cohort and compare them with adult patients with onset between 20 and 40 years of age.Methods. From the EUSTAR SSc cohort two patient groups were analysed: patients with juvenile SSc (jSSc) who are adults at present, and patients diagnosed between the age of 20 and 40 years (aSSc). Demographic data of the patients, organ involvement and outcome of the disease were examined using the Minimal Essential Data Set database system.Results. From 5000 patients in the EUSTAR cohort, 60 patients (1.2%) with jSSc and 910 patients (18%) with aSSc were selected according the inclusion criteria. In the jSSc group, the mean age of disease onset was 12.4 years (range 2-15.9 years), and in the aSSc group, the mean age was 32 years (range 20-40 years). Disease subsets were similar. The antibody profile was also comparable except for ACAs, which were positive in 5% of the jSSc group and 26.9% of the aSSc group (P <0.005). Organ involvement (lung, kidney, joint, muscle and heart) was similar in the two groups of patients at the time of the last follow-up.Conclusion. The subset distribution in the jSSc and aSSc cohorts was found to be similar. Only the frequency of ACAs was significantly lower in the jSSc, which supports the hypothesis that the SSc patients with paediatric onset in the adult cohort may represent a distinct subgroup of the complete cohort of paediatric patients.

Original languageEnglish
Article numberkes144
Pages (from-to)1832-1837
Number of pages6
JournalRheumatology
Volume51
Issue number10
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Systemic Scleroderma
Young Adult
Databases
Research
Pediatrics
Age of Onset
Myocardium
Age Groups
Joints
Demography

Keywords

  • Antibody profile
  • Diffuse subtype
  • EUSTAR
  • Juvenile scleroderma
  • Juvenile systemic sclerosis
  • Limited subtype
  • Organ involvement
  • Outcome
  • Prognosis
  • Systemic sclerosis

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

Foeldvari, I., Tyndall, A., Zulian, F., Müller-Ladner, U., Czirják, L., Denton, C., ... Matucci-Cerinic, M. (2012). Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database. Rheumatology, 51(10), 1832-1837. [kes144]. https://doi.org/10.1093/rheumatology/kes144

Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood : Data from the Eustar database. / Foeldvari, Ivan; Tyndall, Alan; Zulian, Francesco; Müller-Ladner, Ulf; Czirják, L.; Denton, Chris; Kowal-Bielecka, Ottilia; Bancel, Dominique Farge; Matucci-Cerinic, Marco.

In: Rheumatology, Vol. 51, No. 10, kes144, 10.2012, p. 1832-1837.

Research output: Contribution to journalArticle

Foeldvari, I, Tyndall, A, Zulian, F, Müller-Ladner, U, Czirják, L, Denton, C, Kowal-Bielecka, O, Bancel, DF & Matucci-Cerinic, M 2012, 'Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database', Rheumatology, vol. 51, no. 10, kes144, pp. 1832-1837. https://doi.org/10.1093/rheumatology/kes144
Foeldvari, Ivan ; Tyndall, Alan ; Zulian, Francesco ; Müller-Ladner, Ulf ; Czirják, L. ; Denton, Chris ; Kowal-Bielecka, Ottilia ; Bancel, Dominique Farge ; Matucci-Cerinic, Marco. / Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood : Data from the Eustar database. In: Rheumatology. 2012 ; Vol. 51, No. 10. pp. 1832-1837.
@article{57803a2d082b4bfd8fc525c52ee6253a,
title = "Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database",
abstract = "Objective. The aim of the present study was to explore the long-term outcome and clinical characteristics of adult patients with juvenile onset in the EULAR Scleroderma Trials and Research (EUSTAR) cohort and compare them with adult patients with onset between 20 and 40 years of age.Methods. From the EUSTAR SSc cohort two patient groups were analysed: patients with juvenile SSc (jSSc) who are adults at present, and patients diagnosed between the age of 20 and 40 years (aSSc). Demographic data of the patients, organ involvement and outcome of the disease were examined using the Minimal Essential Data Set database system.Results. From 5000 patients in the EUSTAR cohort, 60 patients (1.2{\%}) with jSSc and 910 patients (18{\%}) with aSSc were selected according the inclusion criteria. In the jSSc group, the mean age of disease onset was 12.4 years (range 2-15.9 years), and in the aSSc group, the mean age was 32 years (range 20-40 years). Disease subsets were similar. The antibody profile was also comparable except for ACAs, which were positive in 5{\%} of the jSSc group and 26.9{\%} of the aSSc group (P <0.005). Organ involvement (lung, kidney, joint, muscle and heart) was similar in the two groups of patients at the time of the last follow-up.Conclusion. The subset distribution in the jSSc and aSSc cohorts was found to be similar. Only the frequency of ACAs was significantly lower in the jSSc, which supports the hypothesis that the SSc patients with paediatric onset in the adult cohort may represent a distinct subgroup of the complete cohort of paediatric patients.",
keywords = "Antibody profile, Diffuse subtype, EUSTAR, Juvenile scleroderma, Juvenile systemic sclerosis, Limited subtype, Organ involvement, Outcome, Prognosis, Systemic sclerosis",
author = "Ivan Foeldvari and Alan Tyndall and Francesco Zulian and Ulf M{\"u}ller-Ladner and L. Czirj{\'a}k and Chris Denton and Ottilia Kowal-Bielecka and Bancel, {Dominique Farge} and Marco Matucci-Cerinic",
year = "2012",
month = "10",
doi = "10.1093/rheumatology/kes144",
language = "English",
volume = "51",
pages = "1832--1837",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood

T2 - Data from the Eustar database

AU - Foeldvari, Ivan

AU - Tyndall, Alan

AU - Zulian, Francesco

AU - Müller-Ladner, Ulf

AU - Czirják, L.

AU - Denton, Chris

AU - Kowal-Bielecka, Ottilia

AU - Bancel, Dominique Farge

AU - Matucci-Cerinic, Marco

PY - 2012/10

Y1 - 2012/10

N2 - Objective. The aim of the present study was to explore the long-term outcome and clinical characteristics of adult patients with juvenile onset in the EULAR Scleroderma Trials and Research (EUSTAR) cohort and compare them with adult patients with onset between 20 and 40 years of age.Methods. From the EUSTAR SSc cohort two patient groups were analysed: patients with juvenile SSc (jSSc) who are adults at present, and patients diagnosed between the age of 20 and 40 years (aSSc). Demographic data of the patients, organ involvement and outcome of the disease were examined using the Minimal Essential Data Set database system.Results. From 5000 patients in the EUSTAR cohort, 60 patients (1.2%) with jSSc and 910 patients (18%) with aSSc were selected according the inclusion criteria. In the jSSc group, the mean age of disease onset was 12.4 years (range 2-15.9 years), and in the aSSc group, the mean age was 32 years (range 20-40 years). Disease subsets were similar. The antibody profile was also comparable except for ACAs, which were positive in 5% of the jSSc group and 26.9% of the aSSc group (P <0.005). Organ involvement (lung, kidney, joint, muscle and heart) was similar in the two groups of patients at the time of the last follow-up.Conclusion. The subset distribution in the jSSc and aSSc cohorts was found to be similar. Only the frequency of ACAs was significantly lower in the jSSc, which supports the hypothesis that the SSc patients with paediatric onset in the adult cohort may represent a distinct subgroup of the complete cohort of paediatric patients.

AB - Objective. The aim of the present study was to explore the long-term outcome and clinical characteristics of adult patients with juvenile onset in the EULAR Scleroderma Trials and Research (EUSTAR) cohort and compare them with adult patients with onset between 20 and 40 years of age.Methods. From the EUSTAR SSc cohort two patient groups were analysed: patients with juvenile SSc (jSSc) who are adults at present, and patients diagnosed between the age of 20 and 40 years (aSSc). Demographic data of the patients, organ involvement and outcome of the disease were examined using the Minimal Essential Data Set database system.Results. From 5000 patients in the EUSTAR cohort, 60 patients (1.2%) with jSSc and 910 patients (18%) with aSSc were selected according the inclusion criteria. In the jSSc group, the mean age of disease onset was 12.4 years (range 2-15.9 years), and in the aSSc group, the mean age was 32 years (range 20-40 years). Disease subsets were similar. The antibody profile was also comparable except for ACAs, which were positive in 5% of the jSSc group and 26.9% of the aSSc group (P <0.005). Organ involvement (lung, kidney, joint, muscle and heart) was similar in the two groups of patients at the time of the last follow-up.Conclusion. The subset distribution in the jSSc and aSSc cohorts was found to be similar. Only the frequency of ACAs was significantly lower in the jSSc, which supports the hypothesis that the SSc patients with paediatric onset in the adult cohort may represent a distinct subgroup of the complete cohort of paediatric patients.

KW - Antibody profile

KW - Diffuse subtype

KW - EUSTAR

KW - Juvenile scleroderma

KW - Juvenile systemic sclerosis

KW - Limited subtype

KW - Organ involvement

KW - Outcome

KW - Prognosis

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84867130115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867130115&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kes144

DO - 10.1093/rheumatology/kes144

M3 - Article

C2 - 22728264

AN - SCOPUS:84867130115

VL - 51

SP - 1832

EP - 1837

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 10

M1 - kes144

ER -